UniQure NV (QURE) Common Stock EUR0.05

Sell:$13.85Buy:$13.88$0.46 (3.23%)

NASDAQ:0.52%
Market closed | Prices delayed by at least 15 minutes
Sell:$13.85
Buy:$13.88
Change:$0.46 (3.23%)
Market closed | Prices delayed by at least 15 minutes
Sell:$13.85
Buy:$13.88
Change:$0.46 (3.23%)
Market closed | Prices delayed by at least 15 minutes

Director deals

Listed below are trades carried out by directors and other individuals which are required to be notified to the market.

Recent deals

DateName and position (if held)Deal typeNumber of
shares dealt
Price per
share
Value of
trade
Shares
remaining
20 June 2025
Robert GutDirector
Sell
Tax related
3,336$14.45$48,205.2056,879
20 June 2025
Madhavan BalachandranDirector
Sell
Tax related
2,112$14.45$30,518.4037,697
20 June 2025
Jeremy P SpringhornDirector
Sell
Tax related
2,112$14.45$30,518.4037,694
20 June 2025
David Dunlap Jr MeekDirector
Sell
Tax related
2,112$14.45$30,518.4034,190
20 June 2025
Leonard E PostDirector
Sell
Tax related
2,112$14.45$30,518.4029,937
20 June 2025
Rachelle Suzanne JacquesDirector
Sell
Tax related
2,112$14.45$30,518.4028,346
20 June 2025
Jack L. KayeDirector
Sell
Tax related
2,112$14.45$30,518.4020,439
16 June 2025
Jeannette PottsChief Legal/Compliance Officer
Sell
Tax related
4,670$15.14$70,703.80115,073
4 March 2025
Matthew C KapustaCEO
Sell
Tax related
28,341$10.29$291,628.89651,454
4 March 2025
Christian KlemtCFO
Sell
Tax related
10,438$10.29$107,407.02217,730

5 most significant deals

DateName and position (if held)Deal typeNumber of
shares dealt
Price per
share
Value of
trade
Shares
remaining
10 December 2024
Matthew C KapustaCEO
Sell
Option/Award related
100,000$15.03$1,503,000.00597,915
4 March 2025
Matthew C KapustaCEO
Sell
Tax related
28,341$10.29$291,628.89651,454
25 February 2025
Matthew C KapustaCEO
Sell
Tax related
26,727$10.70$285,978.90571,188
25 February 2025
Christian KlemtCFO
Sell
Tax related
14,341$10.70$153,448.70152,372
4 March 2025
Christian KlemtCFO
Sell
Tax related
10,438$10.29$107,407.02217,730

Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Director deal information provided by Factset.